Hermann Kessler, MD
Colon & Rectal Surgery · Cleveland, OHNPI 1417299363
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.1%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Medtronic at 28.1% of the total. Reporting peaked in 2021 at $2,500 and has fallen 50.1% since, to $1,246 in 2025.
Across 58 payments — averaging $171.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Aroa Biosurgery Incorporated$2K
- Heron Therapeutics, Inc.$1K
- Johnson & Johnson$887
- Covidien LP$505
- Kerecis Limited$384
- plus $2K from 12 others
What the payments were for
- Consulting fees$2,45025%
- Speaking & faculty fees$2,90029%
- Food & beverage$4,57846%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 5 | $2,790 |
| Aroa Biosurgery Incorporated | 11 | $2,223 |
| Heron Therapeutics, Inc. | 1 | $1,400 |
| Johnson & Johnson | 18 | $887 |
| Covidien LP | 4 | $505 |
| Kerecis Limited | 2 | $384 |
| Baxter Healthcare | 4 | $370 |
| Dilon Technologies, Inc. | 2 | $233 |
| Mimedx Group, Inc. | 2 | $220 |
| Davol Inc. | 1 | $137 |
| Prescient Surgical | 1 | $134 |
| Solventum Corporation | 1 | $127 |
| Pacira Pharmaceuticals Incorporated | 1 | $121 |
| Ferring Pharmaceuticals Inc. | 1 | $121 |
| Intuitive Surgical | 1 | $113 |
| Boston Scientific | 1 | $76 |
| Conmed Corporation | 1 | $60 |
| Guard Medical Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HTX-011$1,400
- Kerecis Omega3 SurgiClose$876
- Kerecis Omega3 Marigen$800
- Echelon Circular$286
- Kerecis Omega3 GraftGuide$246
- TISSEEL$236
- Signia$166
- HemoBlast Bellows$159
- Echelon Flex$146
- Harmonic$146
- Enseal$146
- ARISTA AH FLEXITIP$137
- CleanCision$134
- CONTOUR$127
- PREVENA$127
- V.A.C. ULTA$127
- SURGICEL NU-KNIT$123
- EXPAREL$121
- CLENPIQ$121
- Da Vinci Surgical System$113
How this compares
$9,928 in reported general payments places this provider in the 85th percentile of 101 colon & rectal surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 18 | $70 |
| Metronidazole | 18 | $18 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Cleveland
- Vincent ObiasCleveland$124K
- David RosenCleveland$102K
- Jean AshburnCleveland$81K
- Anna SpivakCleveland$54K
- Scott SteeleCleveland$28K
- Michael LiuCleveland$18K
- Conor DelaneyCleveland$16K
- Stefan HolubarCleveland$12K
- David DietzCleveland$11K
- Haniee ChungCleveland$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.